NO751118L - - Google Patents

Info

Publication number
NO751118L
NO751118L NO751118A NO751118A NO751118L NO 751118 L NO751118 L NO 751118L NO 751118 A NO751118 A NO 751118A NO 751118 A NO751118 A NO 751118A NO 751118 L NO751118 L NO 751118L
Authority
NO
Norway
Prior art keywords
interferon
solution
agent
urea
approx
Prior art date
Application number
NO751118A
Other languages
English (en)
Norwegian (no)
Inventor
W E Stewart
P M H F De Somer
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Publication of NO751118L publication Critical patent/NO751118L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO751118A 1974-04-03 1975-04-02 NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7404589A NL7404589A (nl) 1974-04-03 1974-04-03 Werkwijze voor het stabiliseren van interferon.

Publications (1)

Publication Number Publication Date
NO751118L true NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-06

Family

ID=19821109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751118A NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-03 1975-04-02

Country Status (11)

Country Link
US (1) US3981991A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5132725A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU7951275A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE826889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2514537A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK139775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI750951A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2266740B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7404589A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7503769L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
IN150740B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
AU564690B2 (en) 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL74093A0 (en) * 1984-01-23 1985-04-30 Takeda Chemical Industries Ltd Stable composition of gamma-interferon
DE3482307D1 (de) * 1984-09-21 1990-06-28 Vnii Osobo Cistych Biopreparat Rektifizierungsverfahren menschlichen leukozyten-interferons.
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JP2577742B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4950470A (en) * 1986-10-06 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing interferon-gamma
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano

Also Published As

Publication number Publication date
FR2266740B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-12-16
DK139775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-04
FR2266740A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-31
US3981991A (en) 1976-09-21
FI750951A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-04
AU7951275A (en) 1976-09-30
JPS5132725A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-03-19
DE2514537A1 (de) 1975-10-09
BE826889A (nl) 1975-09-22
NL7404589A (nl) 1975-10-07
SE7503769L (sv) 1975-10-06

Similar Documents

Publication Publication Date Title
NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO751117L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Szer et al. Complexing ability and coding properties of synthetic polynucleotides
Müller et al. The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein
Winick Changes in nucleic acid and protein content of the human brain during growth
EP0722492B1 (en) Stabilisation of proteins in solution
Bailey et al. Purification of yeast hexokinase and its reaction with ββ′-dichlorodiethyl sulphide
SE445148B (sv) Forfarande for framstellning av en biologisk komposition for anvendning som en referenskomposition for blodserum vid diagnostisk analys
JPS57140724A (en) Heat-treatment of aqueous solution containing cold insoluble globulin
Tateishi et al. C-terminal truncated Escherichia coli RecA protein RecA5327 has enhanced binding affinities to single-and double-stranded DNAs
JPWO2020047124A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Centrella et al. Regulation of protein synthesis in vesicular stomatitis virus-infected mouse L-929 cells by decreased protein synthesis initiation factor 2 activity
Ballal et al. Dissociation and reconstitution of chromatin without appreciable degradation of the proteins
JP4010573B2 (ja) 低温殺菌中の血漿を安定化するための組成物および治療学的用途のための低温殺菌血漿溶液
TAGUCHI et al. Protein‐protein interaction of fish myosin fragments
Fantl A comparative study of blood coagulation in vertebrates
Alais et al. Isolation, purification, and analysis of two κ-casein-like fractions from sheep casein
JPS6237010B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Meyer et al. Structural studies of the RNA component of the poliovirus replication complex II. Characterization by electron microscopy and autoradiography
Christensen Protamine purification of streptokinase and effect of pH and temperature on reversible inactivation
Treadwell et al. Isolation of protein synthesis initiation factor MP from the high-speed supernatant fraction of wheat germ
KR890008317A (ko) 유전학적 조작에 의한 응고억제성 단백질 pp4의 제조방법
NGON Histone H3 thiol reactivity as a probe of nucleosome structure
Tonomura et al. On the active site of myosin A-adenosine triphosphatase IV. Properties of binding of trinitrobenzenesulfonate and p-chloromercuribenzoate to myosin a
Stewart II et al. Protective effects of anionic detergents on interferons: reversible denaturation